The common diabetes drug metformin can diminish the action of citral against Rhabdomyosarcoma cells in vitro
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma most commonly found in pediatric patients. Despite progress, new and improved drug regimens are needed to increase survival rates. Citral, a natural product plant oil can induce cell death in cancer cells. Another compound, metformin, isol...
Main Authors: | Duan, C, Evison, A, Taylor, L, Onur, S, Morten, K, Townley, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2020
|
Similar Items
-
Improved delivery of the anticancer agent citral using BSA nanoparticles and polymeric wafers.
by: White, B, et al.
Published: (2017) -
Mechanism of action of the sesquiterpene compound helenalin in rhabdomyosarcoma cells
by: Mun, H, et al.
Published: (2021) -
Mechanism of Action of the Sesquiterpene Compound Helenalin in Rhabdomyosarcoma Cells
by: Hakmin Mun, et al.
Published: (2021-12-01) -
Isolation of NELL 1 aptamers for rhabdomyosarcoma targeting
by: Duan, C, et al.
Published: (2022) -
Isolation of NELL 1 Aptamers for Rhabdomyosarcoma Targeting
by: Chengchen Duan, et al.
Published: (2022-04-01)